AXF™ (Advanced Crossflow). For your product development journey from inception to final delivery
Micropore’s range of AXF™ (advanced crossflow) equipment is a unique system that utilises consistent physics, mechanism, conditions and geometry across a range of devices enabling development using a micro device with 100,000 pores delivering as little as 1ml which can be simply accelerated to deliver 20 litres of formulation per hour. And the micro device configuration is seamless transferable to industrial scale units with 10 million pores capable of outputting outputs of 1500 litres per hour."
From the low shear micro mixing required for the production of mRNA loaded lipid nano particles; to dispersed biodegradable PLGA particles with a narrower size distribution; and amorphous crystallisation of APIs for improved bioavailability, Micropore’s patented crossflow membrane technology is revolutionising the world of product formulation.
In pharmaceuticals and biopharmaceuticals, we do much more than the demanding micro- and nanoparticle injectables. Micropore has over 100 years of accumulated expertise in the formulation of different drug product delivery systems.
We can help you engineer your ideal delivery formulation whatever the method you choose:
At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.
Server Render
Unable to load video. Please check that provider and source id have been supplied.
Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.